You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 5, 2024

~ Buy the EDETATE CALCIUM DISODIUM Drug Excipient Business Development Opportunity Report, 2024 PDF Report in the Report Store ~

CLINICAL TRIALS PROFILE FOR EDETATE CALCIUM DISODIUM


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for edetate calcium disodium

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00378781 ↗ Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related Infection Withdrawn National Cancer Institute (NCI) N/A 1969-12-31 RATIONALE: Heparin or M-EDTA may prevent catheter-related infections and blockages in patients at high risk for a catheter-related infection. It is not yet known whether heparin is more effective than M-EDTA in preventing catheter-related infections and blockages in patients at high risk for a catheter-related infection. PURPOSE: This randomized clinical trial is studying heparin to see how well it works compared with M-EDTA in preventing catheter-related infections and blockages in patients at high risk for a catheter-related infection.
NCT00378781 ↗ Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related Infection Withdrawn M.D. Anderson Cancer Center N/A 1969-12-31 RATIONALE: Heparin or M-EDTA may prevent catheter-related infections and blockages in patients at high risk for a catheter-related infection. It is not yet known whether heparin is more effective than M-EDTA in preventing catheter-related infections and blockages in patients at high risk for a catheter-related infection. PURPOSE: This randomized clinical trial is studying heparin to see how well it works compared with M-EDTA in preventing catheter-related infections and blockages in patients at high risk for a catheter-related infection.
NCT01101412 ↗ Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies Withdrawn National Cancer Institute (NCI) Phase 1/Phase 2 1969-12-31 RATIONALE: Antimicrobial solution comprising trimethoprim-sulfamethoxazole, edetate calcium disodium, and ethanol may help prevent blockages and infections from forming in patients with central venous access catheters or peripheral venous catheters. PURPOSE: This randomized trial is studying an antimicrobial solution or saline solution in maintaining catheter patency and preventing catheter-related blood infections in patients with malignancies.
NCT01101412 ↗ Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies Withdrawn M.D. Anderson Cancer Center Phase 1/Phase 2 1969-12-31 RATIONALE: Antimicrobial solution comprising trimethoprim-sulfamethoxazole, edetate calcium disodium, and ethanol may help prevent blockages and infections from forming in patients with central venous access catheters or peripheral venous catheters. PURPOSE: This randomized trial is studying an antimicrobial solution or saline solution in maintaining catheter patency and preventing catheter-related blood infections in patients with malignancies.
NCT02421029 ↗ Prolonged Gadolinium Retention After MRI Imaging Withdrawn Mt. Sinai Medical Center, Miami Phase 4 2017-07-01 The researchers propose to investigate the prevalence of gadolinium in the urine of patients with a prior gadolinium-enhanced MRI before and after a edetate calcium disodium challenge. Moreover, will investigate if there is any correlation of gadolinium urine levels with levels of endogenous (e.g zinc) and xenobiotic metals.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for edetate calcium disodium

Condition Name

Condition Name for edetate calcium disodium
Intervention Trials
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome 1
Lymphoproliferative Disorder 1
Refractory Acute Myeloid Leukemia 1
Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for edetate calcium disodium
Intervention Trials
Myelodysplastic Syndromes 2
Preleukemia 2
Infections 2
Infection 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for edetate calcium disodium

Trials by Country

Trials by Country for edetate calcium disodium
Location Trials
United States 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for edetate calcium disodium
Location Trials
Texas 1
Florida 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for edetate calcium disodium

Clinical Trial Phase

Clinical Trial Phase for edetate calcium disodium
Clinical Trial Phase Trials
Phase 4 1
Phase 1/Phase 2 1
Phase 1 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for edetate calcium disodium
Clinical Trial Phase Trials
Withdrawn 3
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for edetate calcium disodium

Sponsor Name

Sponsor Name for edetate calcium disodium
Sponsor Trials
National Cancer Institute (NCI) 3
M.D. Anderson Cancer Center 3
Mt. Sinai Medical Center, Miami 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for edetate calcium disodium
Sponsor Trials
Other 4
NIH 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.